BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 9040193)

  • 1. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
    Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
    Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
    Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R
    Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
    Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
    Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years].
    Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM
    An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
    Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
    Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.
    Achkar E; Carey W
    Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of adenocarcinoma among patients with Barrett's esophagus.
    Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
    N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.
    Weston AP; Sharma P; Mathur S; Banerjee S; Jafri AK; Cherian R; McGregor D; Hassanein RS; Hall M
    Am J Gastroenterol; 2004 Sep; 99(9):1657-66. PubMed ID: 15330898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of Barrett's high-grade dysplasia.
    Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A
    Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and patient satisfaction with nurse-directed treatment of Barrett's esophagus.
    Schoenfeld P; Johnston M; Piorkowski M; Jones DM; Eloubeidi M; Provenzale D
    Am J Gastroenterol; 1998 Jun; 93(6):906-10. PubMed ID: 9647016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
    Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
    Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.